Emergent BioSolutions-Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates

Emergent Biosolutions (EBS) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of a loss of$ 0.12 per share. This compares to earnings of $1.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +983.33%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.26 per share when it actually produced earnings of $0.16, delivering a surprise of +161.54%.Over t ...